The International Symposium on Neuropsychiatry and Addiction Medicine (ISNAM 2027) is a prestigious international forum dedicated to advancing research, clinical practice, and innovation in the fields of neuropsychiatry, addiction medicine, neuroscience, and mental health. The symposium brings together psychiatrists, neurologists, neuroscientists, addiction specialists, psychologists, clinicians, researchers, academicians, healthcare professionals, policymakers, and industry experts from across the globe to exchange knowledge, present groundbreaking research, and foster interdisciplinary collaborations that improve brain health and mental well-being.
ISNAM 2027 program will feature keynote lectures, plenary sessions, invited talks, oral and poster presentations, panel discussions, workshops, and networking opportunities led by internationally recognized experts. Participants will explore a wide range of topics, including neuropsychiatric disorders, depression, anxiety disorders, schizophrenia, bipolar disorder, cognitive and behavioral neuroscience, substance use disorders, alcohol and opioid addiction, behavioral addictions, dual diagnosis, neuropharmacology, psychopharmacology, neuroimaging, brain stimulation therapies, precision psychiatry, digital mental health, artificial intelligence in mental healthcare, recovery-focused interventions, and emerging therapeutic approaches for neurological and psychiatric disorders.
Join us on May 10–11, 2027, in Kuala Lumpur, Malaysia, for two days of scientific excellence, knowledge exchange, international networking, and collaborative discussions that will shape the future of neuropsychiatry, addiction medicine, and mental healthcare.